188 related articles for article (PubMed ID: 19733597)
1. Age-related behavioural phenotype and cellular characterisation of mice with progressive ablation of D1 dopamine receptor-expressing cells.
Babovic D; Jiang L; Gantois I; Lawrence AJ; Ferreri V; Schütz G; Waddington JL; Drago J
Behav Brain Res; 2010 Jan; 206(1):78-87. PubMed ID: 19733597
[TBL] [Abstract][Full Text] [Related]
2. Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions.
O'Sullivan GJ; Kinsella A; Sibley DR; Tighe O; Croke DT; Waddington JL
Synapse; 2005 Mar; 55(4):201-11. PubMed ID: 15668951
[TBL] [Abstract][Full Text] [Related]
3. Alterations in dopamine and benzodiazepine receptor binding precede overt neuronal pathology in mice modelling early Huntington disease pathogenesis.
Kennedy L; Shelbourne PF; Dewar D
Brain Res; 2005 Mar; 1039(1-2):14-21. PubMed ID: 15781041
[TBL] [Abstract][Full Text] [Related]
4. Resolving pathobiological mechanisms relating to Huntington disease: gait, balance, and involuntary movements in mice with targeted ablation of striatal D1 dopamine receptor cells.
Kim HA; Jiang L; Madsen H; Parish CL; Massalas J; Smardencas A; O'Leary C; Gantois I; O'Tuathaigh C; Waddington JL; Ehrlich ME; Lawrence AJ; Drago J
Neurobiol Dis; 2014 Feb; 62():323-37. PubMed ID: 24135007
[TBL] [Abstract][Full Text] [Related]
5. Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells.
Jiang L; O'Leary C; Kim HA; Parish CL; Massalas J; Waddington JL; Ehrlich ME; Schütz G; Gantois I; Lawrence AJ; Drago J
Neurobiol Dis; 2015 Apr; 76():137-158. PubMed ID: 25684539
[TBL] [Abstract][Full Text] [Related]
6. Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior.
Gantois I; Fang K; Jiang L; Babovic D; Lawrence AJ; Ferreri V; Teper Y; Jupp B; Ziebell J; Morganti-Kossmann CM; O'Brien TJ; Nally R; Schütz G; Waddington J; Egan GF; Drago J
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4182-7. PubMed ID: 17360497
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic disruption to orofacial movement topography in conditional mutants with generalized CamKIIa/Cre D1Tox versus striatal-specific DARPP-32/Cre D1Tox ablation of D1 dopamine receptor-expressing cells.
Tomiyama K; Kim HA; Kinsella A; Ehrlich ME; Schütz G; Koshikawa N; Lawrence AJ; Waddington JL; Drago J
Synapse; 2011 Sep; 65(9):835-42. PubMed ID: 21308794
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor "knockout".
McNamara FN; Clifford JJ; Tighe O; Kinsella A; Drago J; Fuchs S; Croke DT; Waddington JL
Synapse; 2002 Oct; 46(1):19-31. PubMed ID: 12211095
[TBL] [Abstract][Full Text] [Related]
9. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.
Augood SJ; Faull RL; Emson PC
Ann Neurol; 1997 Aug; 42(2):215-21. PubMed ID: 9266732
[TBL] [Abstract][Full Text] [Related]
11. Worsening of Huntington disease phenotype in CB1 receptor knockout mice.
Mievis S; Blum D; Ledent C
Neurobiol Dis; 2011 Jun; 42(3):524-9. PubMed ID: 21406230
[TBL] [Abstract][Full Text] [Related]
12. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.
Le Foll B; Diaz J; Sokoloff P
Life Sci; 2005 Jan; 76(11):1281-96. PubMed ID: 15642598
[TBL] [Abstract][Full Text] [Related]
13. Comparative phenotypic resolution of spontaneous, D2-like and D1-like agonist-induced orofacial movement topographies in congenic mutants with dopamine D2 vs. D3 receptor "knockout".
Tomiyama K; McNamara FN; Clifford JJ; Kinsella A; Drago J; Fuchs S; Grandy DK; Low MJ; Rubinstein M; Tighe O; Croke DT; Koshikawa N; Waddington JL
Synapse; 2004 Jan; 51(1):71-81. PubMed ID: 14579426
[TBL] [Abstract][Full Text] [Related]
14. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
[TBL] [Abstract][Full Text] [Related]
15. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats.
Carta M; Stancampiano R; Tronci E; Collu M; Usiello A; Morelli M; Fadda F
Neuroscience; 2006; 139(4):1163-72. PubMed ID: 16530976
[TBL] [Abstract][Full Text] [Related]
16. The effect of D1-like receptor blockade on motor functions and spatial learning in B6CBA mice.
Voller J; Donek A; Cendelń J; Korelusová I; Vozeh F
Prague Med Rep; 2008; 109(1):32-9. PubMed ID: 19097388
[TBL] [Abstract][Full Text] [Related]
17. Role of dopamine receptors subtypes, D1-like and D2-like, within the nucleus accumbens subregions, core and shell, on memory consolidation in the one-trial inhibitory avoidance task.
Managò F; Castellano C; Oliverio A; Mele A; De Leonibus E
Learn Mem; 2009 Jan; 16(1):46-52. PubMed ID: 19117916
[TBL] [Abstract][Full Text] [Related]
18. Expression of D1 but not D2 dopamine receptors in striatal neurons producing neurokinin B in rats.
Sonomura T; Nakamura K; Furuta T; Hioki H; Nishi A; Yamanaka A; Uemura M; Kaneko T
Eur J Neurosci; 2007 Dec; 26(11):3093-103. PubMed ID: 18028111
[TBL] [Abstract][Full Text] [Related]
19. Delayed, context- and dopamine D1 receptor-dependent activation of ERK in morphine-sensitized mice.
Borgkvist A; Valjent E; Santini E; Hervé D; Girault JA; Fisone G
Neuropharmacology; 2008 Aug; 55(2):230-7. PubMed ID: 18614186
[TBL] [Abstract][Full Text] [Related]
20. Behavioural and anatomical characterization of mutant mice with targeted deletion of D1 dopamine receptor-expressing cells: response to acute morphine.
Babovic D; Jiang L; Goto S; Gantois I; Schütz G; Lawrence AJ; Waddington JL; Drago J
J Pharmacol Sci; 2013; 121(1):39-47. PubMed ID: 23337398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
